Veeva's Vault CRM Secures 14th Top 20 Biopharma Client
Event summary
- Veeva Systems announced another top 20 biopharma commitment for Vault CRM, bringing total live customers to 190 and commitments from 14 of the top 20 biopharmas.
- Recent selections include Amgen, Biogen, Eli Lilly, and Regeneron.
- Vault CRM introduces agentic capabilities like the Agentic Call Report to enhance field productivity and customer engagement.
- The platform connects sales, marketing, and medical teams for compliant, customer-centric engagement.
The big picture
Veeva's Vault CRM is positioning itself as the next-generation CRM for the biopharma industry, leveraging AI and agentic capabilities to transform how companies engage with healthcare professionals. The rapid adoption by top biopharma firms underscores a broader industry shift towards more efficient, data-driven commercial strategies. With 14 of the top 20 biopharmas now committed, Veeva is solidifying its market leadership in a sector increasingly reliant on digital transformation.
What we're watching
- Market Penetration
- Whether Veeva can maintain its momentum in securing commitments from the remaining top 20 biopharmas.
- Product Differentiation
- How the agentic capabilities of Vault CRM will impact competitive positioning against traditional CRM solutions.
- Industry Adoption
- The pace at which biopharma companies transition to next-generation CRM platforms like Vault.